...acquired a VEGF-B mAb program as part of its 2006 purchase of fellow Australian biotech Zenyth Therapeutics Ltd....
...Ltd. on uncovering VEGF-B's function. Nash said that this 10-year-long collaboration has continued now that Zenyth...

...disclose the clinical status of any resulting compounds. The original deal was between MuriGen and Zenyth Therapeutics Ltd....

...David Crump, formerly head of development projects and medical advisor at Amrad Corporation Ltd. (now Zenyth Therapeutics Ltd....

...AZN completes its acquisition of Cambridge Antibody Technology plc. CAT, which is collaborating with CSL's Zenyth Therapeutics Ltd....

...will meet on Oct. 23 to vote on the acquisition. CSL Ltd. (ASX:CSL), Melbourne, Australia Zenyth Therapeutics Ltd....

...see "Endocrine Boosting," A9). Meanwhile, CSL (ASX:CSL) is also shelling out a premium to acquire Zenyth...

...Two decades after it was founded and one decade after it went public, Zenyth Therapeutics Ltd. is being...
...being acquired by fellow Australian company CSL Ltd. for A$102.7 million ($77.3 million) in cash. Zenyth...
...year, and the stock has not risen above A$1 since. Amrad changed its name to Zenyth...

...is being acquired by AstraZeneca plc (LSE:AZN; AZN, London, U.K.). CSL Ltd. (ASX:CSL), Melbourne, Australia Zenyth Therapeutics Ltd....

...CSL (ASX:CSL) will acquire Zenyth (ASX:ZTL) for A$0.82 per share, or about A$102.7 million (US$77.3 million...

...a preclinical IL-13 receptor antibody to treat asthma, did not disclose what triggered the milestone. Zenyth Therapeutics Ltd....